Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages

Journal of Virology

Volumn 73, Issue 10, 1999, Pages 8541-8548

  Hirasawa, K ^a   Jun, H S ^a   Han, H S ^a   Zhang, M L ^a   Hollenberg, M D ^b   Yoon, J W ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Ajou University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL DESTRUCTION; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; ENZYME ACTIVATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS INFECTION;

EID: 0032862978     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.10.8541-8548.1999     Document Type: Article

References (36)

1. Baek, H. S., and J. W. Yoon. 1990. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 64:5708-5715.
2. Baek, H. S., and J. W. Yoon. 1991. Direct involvement of macrophages in the destruction of beta cells leading to development of diabetes in virus-infected mice. Diabetes 40:1586-1596.
3. Bowman, M., O. Simell, Z. Look, R. Luchetta, and M. Atkinson. 1994. Pharmacokinetic and therapeutic analysis of aminoguanidine. Diabetes 43(Suppl. 1):235A.
4. Bruder, J. T., and I. Kovesdi. 1997. Adenovirus infection stimulates the Raf/MAPK signalling pathway and induces interleukin-8 expression. J. Virol. 71:398-404.
5. Chan, E. D., B. W. Winston, S. T. Uh, M. W. Wynes, D. M. Rose, and W. Riches. 1999. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages. J. Immunol. 162:415-422.
6. Chung, Y. H., H. S. Jun, K. Hirasawa, B. R. Lee, N. van Rooijen, and J. W. Yoon. 1997. Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BB rats. J. Immunol. 159:446-471.
7. Craighead, J. E., and M. F. McLane. 1968. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 162:913-915.
8. Faust, A., R. Kleemann, H. Rothe, and H. Kolb. 1996. Role of macrophages and cytokines in beta cell death, p. 47-56. In E. Shafrir (ed.), Lessons from animal diabetes VI. Birkhauser Boston, Cambridge, Mass.
9. Fischer, S. N., Y. U. Kim, and M. L. Shin. 1994. Tyrosine kinase activation by Newcastle disease virus is required for TNF-α gene induction in astrocytes. J. Immunol. 153:3210-3217.
10. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
11. Guberski, D. L., V. A. Thomas, W. R. Shek, A. A. Like, E. S. Handler, A. A. Rossini, J. E. Wallace, and R. M. Welsh. 1991. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 254:1010-1013.
12. Hirasawa, K., H. S. Jun, K. Maeda, Y. Kawaguchi, S. Itagaki, T. Mikami, H. S. Baek, K. Doi, and J. W. Yoon. 1997. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes. J. Virol. 71:4024-4031.
13. Hirasawa, K., M. Takeda, S. Itagaki, and K. Doi. 1996. Involvement of macrophages in the development of encephalomyocarditis virus (EMC)-induced diabetes. Exp. Anim. 45:77-80.
14. Hirasawa, K., S. Tsutsui, M. Takeda, M. Mizutani, S. Itagaki, and K. Doi. 1996. Depletion of Mac-1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes. J. Gen. Virol. 77:737-741.
15. Huttunen, P., T. Hyypia, P. Vihnen, L. Nissinen, and J. Heino. 1998. Echovirus 1 infection induces both stress and growth-activated mitogen activated protein kinase pathways and regulates the transcription of cellular immediate early genes. Virology 250:85-93.
16. Jun, H. S., Y. Kang, A. L. Notkins, and J. W. Yoon. 1997. Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. J. Virol. 71:9782-9785.
17. Jun, H. S., Y. Kang, H. S. Yoon, K. H. Kim, A. L. Notkins, and J. W. Yoon. 1998. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes 47:576-582.
18. Kaneto, H., J. Fujii, H. S. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, and N. Taniguchi. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44:733-738.
19. Kang, Y., and J. W. Yoon. 1993. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice. J. Gen. Virol. 74:1207-1213.
20. Kleemann, R., H. Rothe, V. Kolb-Bachofen, Q. W. Xie, C. Nathan, S. Martin, and H. Kolb. 1993. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 328:9-12.
21. w-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44:365-368.
22. McDaniel, M. L., G. Kwon, J. R. Hill, C. A. Marshall, and J. A. Corbett. 1996. Cytokine and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211:24-32.
23. Novogrodsky, A., A. Vanichkin, M. Patya, A. Gazit, N. Osherov, and A. Levitzki. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322.
24. Rossini, A. A., D. L. Greiner, H. P. Friedman, and J. P. Mordes. 1993. Immunopathogenesis of diabetes mellitus. Diabetes Rev. 1:43-75.
25. She, J. X. 1996. Susceptible to type 1 diabetes: HLA-DQ and DR revisited. Immunol. Today 17:323-329.
26. Stassi, G., R. De Maria, G. Trucco, W. Rudert, R. Tesiti, A. Galluzzo, C. Giordano, and M. Trucco. 1997. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1193-1200.
27. Tisch, R., and H. McDevltt. 1996. Insulin-dependent diabetes mellitus. Cell 85:291-297.
28. Vanichkin, A., M. Patya, A. Gazit, A. Levitzki, and N. Novogrodsky. 1996. Late administration of a lipophilic tyrosine kinase inhibitor prevents lipo-polysaccharide and Escherichia coli-induced lethal toxicity. J. Infect. Dis. 173:927-933.
29. Yoon, J. W. 1995. A new look at viruses in type 1 diabetes. Diabetes Metab. Rev. 11:83-107.
30. Yoon, J. W. 1997. Pathogenesis of IDDM: environmental factors, p. 1-14. In J. Pickup and G. Williams (ed.), Textbook of diabetes. Blackwell Scientific Publications, London, England.
31. Yoon, J. W., and H. S. Jun. 1998. Insulin-dependent diabetes mellitus, p. 1390-1398. In I. M. Roitt and P. J. Delves (ed.), Encyclopedia of immunology, 2nd ed. Academic Press, London, England.
32. Yoon, J. W., M. A. Lesniak, R. Fussganger, and A. L. Notkins. 1976. Genetic differences in susceptibility of pancreatic β-cells to virus-induced diabetes mellitus. Nature 264:178-180.
33. Yoon, J. W., P. R. McClintock, C. J. Bachurski, J. D. Longstreth, and A. L. Notkins. 1985. Virus-induced diabetes mellitus: no evidence for immune mechanisms in the destruction of β-cells by the D-variant encephalomyocarditis virus. Diabetes 34:922-925.
34. Yoon, J. W., P. R. McClintock, T. Onodera, and A. L. Notkins. 1980. Virus-induced diabetes mellitus. XVIII. Inhibition by a non-diabetogenic variant of encephalomyocarditis virus. J. Exp. Med. 152:878-892.
35. Yoon, J. W., M. M. Rodrigues, C. Currier, and A. L. Notkins. 1982. Longterm complications of virus-induced diabetes in mice. Nature 296:567-569.
36. Yoon, J. W., A. K. C. Wong, Y. S. Bae, and H. M. Eun. 1988. An apparent deletion of an oligonucleotide detected by RNA fingerprint in the nondia-betogenic B variant of encephalomyocarditis virus is caused by a point mutation. J. Virol. 62:637-640.